HIGHLIGHTS
- who: Shuai Chen and Chunjie Sheng from the Nantes-Atlantique (Oniris), France AandM University, United States have published the research work: The Food and Drug Administration-approved antipsychotic drug trifluoperazine, a calmodulin antagonist, inhibits viral replication through PERK-eIF2a axis, in the Journal: (JOURNAL)
- how: The data were analyzed with SPSS software and generated using GraphPad Prism 8. For three and more independent groups the authors used one-way ANOVA with Bonferroni`s post-test. As expected qPCR results showed that the expression level of CALM1/2/3 was much higher than DRD2 which was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.